login
login

Europe Daily Bulletin No. 12521

7 July 2020
Contents Publication in full By article 15 / 33
EU RESPONSE TO COVID-19 / Research
EIB and CureVac conclude €75 million loan agreement
Brussels, 06/07/2020 (Agence Europe)

On Monday 6 July, the European Investment Bank (EIB) and the German biopharmaceutical company CureVac (see EUROPE B12507A28) signed a €75 million loan agreement to support the development and large-scale production of vaccines, particularly vaccines to combat Covid-19.

The money - which is slightly less than the €80 million initially announced by the European Commission (see EUROPE B12447A1) - will be granted in three tranches of €25 million.

The money will be raised through InnovFin,...

Contents

SECTORAL POLICIES
EU RESPONSE TO COVID-19
EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
NEWS BRIEFS
Kiosk